Exam 2: Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease

Clinical Gastroenterology and Hepatology 2017;15:e10

Exam 2: Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease Test ID No.: 0251

Contact Hours: 1.0

Expiration Date: January 31, 2018

Question 1: Which of the following is not a gastrointestinal manifestation of autosomal dominant polycystic kidney disease (ADPKD)?

a. b. c. d. e.

Hernias Pancreatic cysts Common bile duct dilation Esophageal duplication cysts Liver cysts

Question 2: Which of the following is false regarding somatostatin analogue therapy for liver cystic disease in ADPKD?

a. Efficacy does not depend on the size of the polycystic liver b. Younger woman have a greater response compared to older women c. The range of mean reductions in liver volume in the randomized controlled trials involving somatostatin analogues was 15%–20% d. The most common side effects are abdominal cramps and diarrhea

Question 3: Does the Kidney Disease Improving Global Outcomes recommend routine screening for diverticulosis in patients with ADPKD and end-stage renal disease?

a. Yes b. No

Question 4: What is the frequency and most common type of pancreatic cysts seen in patients with ADPKD?

a. b. c. d.

9%; single, unilocular 9%; single, multilocular 12%; multiple, unilocular 12%; multiple, multilocular